SEC 13F Intelligence

Frazier Management LLC / PHAT

Frazier Management LLC’s Phathom Pharmaceuticals Inc Position

Does Frazier Management LLC own Phathom Pharmaceuticals Inc (PHAT)? Not currently — the last reported position was 5.83M shares worth $115M in Q4 2021; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$115M
Q4 2021
Shares
5.83M
% of Portfolio
+8.82%
Quarters Held
9
position exited

Position History PHAT

Reported value by quarter
Q4 ’19: $227MQ4 ’19Q1 ’20: $188MQ2 ’20: $192MQ2 ’20Q3 ’20: $214MQ4 ’20: $194MQ4 ’20Q1 ’21: $219MQ2 ’21: $197MQ2 ’21Q3 ’21: $187MQ4 ’21: $115MQ4 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20215.83M$115M+8.82%
Q3 20215.83M$187M+14.97%
Q2 20215.83M$197M+18.19%
Q1 20215.83M$219M+17.56%
Q4 20205.83M$194M+14.91%
Q3 20205.83M$214M+19.18%
Q2 20205.83M$192M+16.84%
Q1 20207.28M$188M+21.32%
Q4 20197.28M$227M+38.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Frazier Management LLC’s full portfolio or all institutional holders of PHAT.